Time-to-reach Target Calprotectin Level in Newly Diagnosed Patients With Inflammatory Bowel Disease

OBJECTIVES: Treatment targets in inflammatory bowel disease (IBD) move away from controlling symptoms towards complete recovery of the intestinal mucosa. Currently, the most frequently used noninvasive surrogate marker of mucosal healing is a faecal calprotectin concentration in the target range. Th...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Pediatr Gastroenterol Nutr
Autors principals: Haisma, Sjoukje-Marije, Verkade, Henkjan J., Scheenstra, Rene, van der Doef, Hubert P.J., Bodewes, Frank A.J.A., van Rheenen, Patrick F.
Format: Artigo
Idioma:Inglês
Publicat: Lippincott Williams & Wilkins 2019
Matèries:
Original Articles: Gastroenterology: Inflammatory Bowel Disease
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6750145/
https://ncbi.nlm.nih.gov/pubmed/31365486
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MPG.0000000000002458
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars